NEVPF

Neurovive Pharmaceutical AB

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Sanders Ortoli Vaughn-Flam Rosenstadt LLP
Verified Company Profile 8/26/2016
Contact Info
  • Medicon Village
  • Scheelevagen 2
  • Lund 223 81
  • Sweden

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: OMX Nordic Exchange Stockholm
Audited Financials Audited
Latest Report Sep 30, 2016 Interim Financial Report
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Sweden
Year of Inc. 2000
Employees 12 a/o Jun 01, 2016
Company Officers/Contacts
Erik Kinnman CEO
Catharina Jz Johansson CFO
Magnus Hansson CMO
Eskil Elmer CSO
Cecilia Hofvander Director, Inv. Rel.
Company Directors
Gregory Batcheller Executive Chairman
Service Providers
OTCQX Advisor
Sanders Ortoli Vaughn-Flam Rosenstadt LLP
501 Madison Avenue
14th Floor
New York, NY, 10022
USA

Accounting/Auditing Firm
Mazars
61 rue Henri Regnault
92075 Paris La Defense Cedex
France

Ernst & Young AB
Sweden

Legal Counsel
Not Available
Investor Relations Firm
Not Available
NEVPF Security Details
Share Structure
Market Value1 $14,837,594 a/o Dec 06, 2016
Authorized Shares 49,458,645 a/o Dec 30, 2015
Outstanding Shares 49,458,645 a/o Dec 30, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 17,248,125 a/o Dec 30, 2015
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
NVP - OMX Nordic Exchange Stockholm - Qualified
Short Selling Data
Short Interest 7,100 (-88.47%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security